Diagnostics firm adds investor to bring funding over $20M
Prenosis is aiming for FDA clearance this year for a diagnostic tool for sepsis, a condition that kills millions of people each year.
PACE Healthcare Capital
Prenosis is aiming for FDA clearance this year for a diagnostic tool for sepsis, a condition that kills millions of people each year.